Data / Crowdfunding / California / Eliaz Therapeutics Inc.
Eliaz Therapeutics Inc.: crowdfunding raise on DEALMAKER SECURITIES LLC, $10,004 to $2,999,995 (2026)
Eliaz Therapeutics Inc., a corporation in Santa Rosa, CA, filed a Form C with the SEC on June 10, 2026 to raise $10,004 to $2,999,995 in Class B Common Stock through DEALMAKER SECURITIES LLC. The offering closes on April 15, 2027. In its most recent fiscal year it reported $332,235 in revenue and a net loss of $1,745,041, with 2 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.eliaztherapeutics.com
- Funding portal
- DEALMAKER SECURITIES LLC
- Address
- 398 TESCONI COURT, Santa Rosa, CA 95401
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- September 17, 2015
- SEC CIK
- 0002042609
Offering terms
From the offering filed June 10, 2026.
- Security
- Class B Common Stock
- Price
- $5.56
- Target
- $10,004
- Maximum
- $2,999,995
- Deadline
- April 15, 2027
- Portal compensation
- The Issuer will pay DealMaker Securities LLC an 8.5% cash commission fee based on the dollar amount of the Securities sold in the Offering. There is also a one-time $38,000 fee and a $15,000 monthly fee payable to DealMaker Securities LLC or its affiliates
Financials
From the Form C-U filed July 7, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $332,235 | $302,481 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-1,745,041 | $-954,869 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $2,589,276 | $738,015 | sec.gov |
| Cash | $1,799,510 | $32,814 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $1,796,731 | $2,346,085 | sec.gov |
| Long-term debt | $8,033,117 | $3,888,186 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| July 7, 2026 | Progress update | $10,004 | $2,999,995 | April 15, 2027 | The Offering successfully reached its Target Offering Amount on July 6, 2026, having closed on funds totaling $42,352.43. | sec.gov |
| June 10, 2026 | Offering | $10,004 | $2,999,995 | April 15, 2027 | sec.gov | |
| May 4, 2026 | Progress update | $19,999 | $2,490,574 | April 30, 2026 | At the close of the offering, the issuer closed on $470,059.08 and 93,423 number of securities. | sec.gov |
| April 29, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| March 3, 2026 | Amendment | $19,999 | $2,490,574 | April 30, 2026 | Campaign is Extending to April 30 2026 and adding flash perks | sec.gov |
| December 8, 2025 | Offering | $19,999 | $2,490,574 | March 9, 2026 | sec.gov | |
| November 28, 2025 | Progress update | $50,000 | $3,000,000 | April 30, 2026 | The final number is $2,509,425.00 in investments. | sec.gov |
| August 7, 2025 | Amendment | $50,000 | $3,000,000 | April 30, 2026 | Adjusting VIP | sec.gov |
| July 22, 2025 | Amendment | $50,000 | $3,000,000 | April 30, 2026 | Lowering fee | sec.gov |
| June 13, 2025 | Amendment | $50,000 | $3,000,000 | April 30, 2026 | Adding audited financials and increasing maximum | sec.gov |
| April 25, 2025 | Amendment | $50,000 | $1,235,000 | April 30, 2026 | Adding 2024 financials and extending. | sec.gov |
| March 31, 2025 | Amendment | $50,000 | $1,235,000 | April 30, 2025 | Increasing Early Bird threshold | sec.gov |
| March 25, 2025 | Amendment | $50,000 | $1,235,000 | April 30, 2025 | Increasing Early Bird threshold | sec.gov |
| November 7, 2024 | Offering | $50,000 | $1,235,000 | April 30, 2025 | sec.gov |
Also on SpecStream
Updated July 7, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.